Search Within

Heiko Schoder

  1. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (68)
  2. Journal Article (61)
  3. Book Section (1)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (132)
  2. Molecular Imaging and Therapy Service (132)
  3. Radiology, Department of (132)
  4. Solid Tumor Oncology Division (132)
  5. Survivorship Research (61)
  6. Epidemiology and Biostatistics (60)

More Groups

People
  1. John Humm (38)
  2. Nancy Lee (32)
  3. Steven Larson (32)
  4. Eric Sherman (30)
  5. Howard Scher (25)
  6. Michael Morris (25)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (11)
  4. 2022 (9)
  5. 2021 (11)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (39)
  2. International Journal of Radiation Oncology, Biology, Physics (17)
  3. Journal of Nuclear Medicine (15)
  4. Blood (8)
  5. Clinical Cancer Research (4)
  6. European Journal of Nuclear Medicine and Molecular Imaging (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. Elsevier Inc. (22)
  3. Society of Nuclear Medicine (15)
  4. Springer (13)
  5. American Society of Hematology (8)
  6. American Association for Cancer Research (7)

More Publishers

Results (132)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Prostate Cancer Clinical Trials Consortium (PCCTC) bone scan data capture tool for clinical trials using Prostate Cancer Working Group 2 (PCWG2) criteria: Effect on data accuracy and workload
    Meeting Abstract

    Morris, M. J.; Farrelly, J. S.; Fox, J. J.; Dennis, E. R.; Schwartz, L. H.; Schoder, H.; Haupt, E. C.; Borwick, L. S.; Larson, S. M.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Primary tumor metabolic volume improves risk prediction of long-term outcomes in patients with oropharyngeal squamous cell carcinoma treated with intensity modulated radiation therapy (IMRT) and chemotherapy
    Meeting Abstract

    Lim, R. C.; Schoder, H.; Eaton, A.; Gonen, M.; Rao, S.; Sherman, E.; Wong, R.; Setton, J.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • A pilot study of using pre- and early (1 week) [18f]-misonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) scans as an early treatment response predictor in a series of head and neck cancer (HNC) patients undergoing chemoradiation
    Meeting Abstract

    Lee, N.; Bartlett, R.; Lian, M.; Fury, M.; Sherman, E.; Wong, R.; Zanzonico, P. B.; Schoder, H.; Humm, J.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT
    Journal Article

    Fox, J. J.; Autran-Blanc, E.; Morris, M. J.; Gavane, S.; Nehmeh, S.; Van Nuffel, A.; Gonen, M.; Schoder, H.; Humm, J. L.; Scher, H. I.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • Developing imaging strategies for castration resistant prostate cancer
    Journal Article

    Fox, J. J.; Morris, M. J.; Larson, S. M.; Schoder, H.; Scher, H. I.
    Acta Oncologica (2011)

    Fulltext@MSK | Save
  • Perioperative chemotherapy plus bevacizumab with early salvage therapy based on PET response in patients with locally advanced resectable gastric/GEJ cancer
    Meeting Abstract

    Smyth, E. C.; Schoder, H.; Coit, D. G.; Strong, V. E.; Brennan, M. F.; Janjigian, Y. Y.; Capanu, M.; Tang, L. H.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II study of VEGF trap (aflibercept) in patients with radioactive iodine-refractory, positron emission tomography (PET) positive thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Haque, S.; Ghossein, R. A.; Lisa, D. M.; Schoder, H.; Baum, M. S.; Shaha, A. R.; Tuttle, R. M.; Pfister, D. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Fluorodeoxyglycose (FDG) PET as an outcome measure for metastatic prostate cancer
    Meeting Abstract

    Morris, M. J.; Fox, J. J.; Dennis, E. R.; Tse, K.; Flatts, E.; Heller, G.; Jia, X.; Schoder, H.; Larson, S. M.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Target volume delineation in oropharyngeal cancer: Impact of PET, MRI and physical examination
    Meeting Abstract

    Thiagarajan, A.; Caria, N.; Schoder, H.; Iyer, N.; Wolden, S.; Wong, R. J.; Kraus, D. H.; Sherman, E.; Fury, M. G.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save
  • Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer
    Journal Article

    Apolo, A. B.; Riches, J.; Schoder, H.; Akin, O.; Trout, A.; Milowsky, M. I.; Bajorin, D. F.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save